Aristo Bio-Tech & Lifescience
add_icon

Aristo Bio-Tech & Lifescience

81.75
+3.85
(4.94%)
Market Cap
55.65 Cr
PE Ratio
13.05
Volume
2,400.00
Day High - Low
81.75 - 74.30
52W High-Low
148.00 - 75.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
55.65 Cr
EPS
5.97
PE Ratio
13.05
PB Ratio
1.42
Book Value
54.84
EBITDA
9.70
Dividend Yield
0.64 %
Industry
Chemicals
Return on Equity
10.88
Debt to Equity
0.60
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
593.00
#1 50,059.24
25.03
#1 47,123.00
8.13
820
-42.56
40.17
2,797.20
42,438.59
29.75
8,322.00
5.70
#1 1,660
-16.47
40.86
4,759.90
21,391.99
31.72
5,593.10
7.89
568
179.82
59.19
383.30
19,132.26
35.70
3,268.60
11.19
506
-13.27
46.24
887.30
8,005.26
#1 14.18
4,379.40
#1 35.89
304
#1 366.56
35.71
234.89
4,567.88
31.33
2,631.40
6.54
164
-274.07
42.84
962.90
4,340.59
14.32
2,071.30
15.49
297
27.97
45.18
138.15
3,232.89
-68.74
1,242.60
-30.48
-92
71.82
55.61
197.24
2,557.59
190.98
449.80
9.63
14
27.78
52.32
1,410.20
2,343.90
16.34
1,199.00
12.53
141
-1.23
50.54
Growth Rate
Revenue Growth
29.84 %
Net Income Growth
5.13 %
Cash Flow Change
31.84 %
ROE
-6.13 %
ROCE
-2.59 %
EBITDA Margin (Avg.)
-13.60 %

Yearly Financial Results

Annual Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
58
161
272
202
201
167
166
218
245
319
0
Expenses
56
158
264
195
197
163
161
209
237
309
0
EBITDA
1
4
8
7
5
4
5
9
9
10
0
Operating Profit %
2 %
2 %
3 %
3 %
2 %
3 %
3 %
4 %
3 %
3 %
0 %
Depreciation
0
0
1
1
1
1
1
2
2
3
0
Interest
1
1
2
2
3
2
2
3
2
2
0
Profit Before Tax
1
3
6
4
1
2
2
5
5
6
0
Tax
0
1
2
1
0
0
1
1
2
1
0
Net Profit
0
2
4
3
1
1
1
4
4
4
0
EPS in ₹
3.98
18.53
37.41
5.66
2.02
2.15
2.87
6.72
5.72
5.97
0.00

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
27
87
89
91
88
81
77
100
127
141
Fixed Assets
2
2
3
8
8
12
14
16
22
24
Current Assets
25
84
81
81
77
69
63
83
105
116
Capital Work in Progress
0
0
0
2
3
0
0
1
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
25
85
86
81
77
69
63
83
106
117
Total Equity & Liabilities
27
87
89
91
88
81
77
100
127
141
Current Liabilities
24
78
70
72
65
56
51
60
84
96
Non Current Liabilities
0
5
11
7
11
12
11
10
10
8
Total Equity
3
5
9
11
12
13
15
30
34
37
Reserve & Surplus
2
4
8
6
7
8
10
23
27
31
Share Capital
1
1
1
5
5
5
5
7
7
7

Cash Flow

Cash Flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
-0
-0
0
-0
0
1
-1
1
Investing Activities
0
-5
-2
-2
-2
-3
-4
-7
-5
Operating Activities
-4
1
8
1
2
7
-3
8
10
Financing Activities
4
4
-6
1
-1
-3
8
-2
-4

Share Holding

% Holding
Apr 2022
Jan 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Sept 2025
Promoter
100.00 %
73.37 %
73.37 %
73.37 %
73.37 %
73.37 %
73.42 %
73.42 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
24.28 %
22.14 %
22.84 %
24.18 %
23.69 %
23.10 %
24.14 %
Others
0.00 %
2.35 %
4.49 %
3.78 %
2.44 %
2.94 %
3.48 %
2.44 %
No of Share Holders
7
1,004
660
652
742
625
512
468

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.4 0.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.4 0.34 0.67 0.00

Technical Indicators

RSI(14)
Neutral
37.74
ATR(14)
Volatile
4.13
STOCH(9,6)
Neutral
20.56
STOCH RSI(14)
Neutral
35.61
MACD(12,26)
Bearish
-0.06
ADX(14)
Weak Trend
22.93
UO(9)
Bearish
55.99
ROC(12)
Downtrend And Accelerating
-13.95
WillR(14)
Neutral
-68.57